Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  AJP - Renal Physiology

• Publication date

  1999-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/ajprenal.1999.277.6.F966PMID 10600944
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential Expression of Peroxisome Proliferator-Activated Receptors (PPARs): Tissue Distribution of PPAR-a, $3, and -y in the Adult Rat*

  2001influential reference
• Differential expression of PPAR gamma1 and gamma2 isoforms in human adipose tissue.

  1997cited by this paper
• Differential expression of PPAR γ1 and γ2 isoforms in human adipose tissue

  1997cited by this paper
• Regulating Adipogenesis*

  1997cited by this paper
• Cyclic nucleotide-gated cation channels mediate sodium absorption by IMCD (mIMCD-K2) cells.

  1997cited by this paper
• Effects of thiazolidinediones on growth and differentiation of human aorta and coronary myocytes.

  1997cited by this paper
• PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.

  1997cited by this paper
• Identification, Characterization, and Tissue Distribution of Human Peroxisome Proliferator-activated Receptor (PPAR) Isoforms PPARγ2 versus PPARγ1 and Activation with Retinoid X Receptor Agonists and Antagonists*

  1997cited by this paper
• Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans.

  1997cited by this paper
• Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.

  1996cited by this paper
• Localization of bumetanide- and thiazide-sensitive Na-K-Cl cotransporters along the rat nephron.

  1996cited by this paper
• The PPARα–leukotriene B4 pathway to inflammation control

  1996cited by this paper
• The PPARalpha-leukotriene B4 pathway to inflammation control.

  1996cited by this paper
• CFTR expression in cortical collecting duct cells.

  1996cited by this paper
• The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.

  1996cited by this paper
• Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice.

  1996cited by this paper
• Rat PPAR delta contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei.

  1995cited by this paper
• 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ

  1995cited by this paper
• A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.

  1995cited by this paper
• 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.

  1995cited by this paper
• The nuclear receptor superfamily: the second decade.

  1995cited by this paper
• Rat PPARδ Contains a CGG Triplet Repeat and Is Prominently Expressed in the Thalamic Nuclei

  1995cited by this paper
• Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.

  1994influential reference
• mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.

  1994cited by this paper
• Peroxisome proliferator-activated receptors A link between endocrinology and nutrition?

  1993cited by this paper
• Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives, feeding and liver proliferation.

  1993cited by this paper
• Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor.

  1993cited by this paper
• Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids.

  1993cited by this paper
• Biological activities and mechanisms of action of PGJ2 and related compounds: an update.

  1992cited by this paper
• Dynamics of atrial natriuretic factor-guanylate cyclase receptors and receptor-ligand complexes in cultured glomerular mesangial and renomedullary interstitial cells.

  1992cited by this paper
• Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor.

  1992cited by this paper
• Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors.

  1992cited by this paper
• RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements.

  1991cited by this paper
• RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements

  1991cited by this paper
• Structure and regulation of rat long-chain acyl-CoA synthetase.

  1990cited by this paper
• Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

  1990cited by this paper
• Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition.

  1986cited by this paper
• Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei.

  1986cited by this paper
• [Prostaglandins and the kidney].

  1986cited by this paper
• Chronotropic response of spontaneously beating rabbit atria to hyperosmotic media.

  1977cited by this paper
• Characterization of prostaglandin production in tissue culture of rat renal medullary cells.

  1976cited by this paper
• Peroxisome development in the regenerating pars recta (P3 segment) of proximal tubules of the rat kidney.

  1976cited by this paper

• Light-regulated microRNAs shape dynamic gene expression in the zebrafish circadian clock

  2025cites this paper
• Variants in tubule epithelial regulatory elements mediate most heritable differences in human kidney function

  2024cites this paper
• The global perspective on peroxisome proliferator-activated receptor γ (PPARγ) in ectopic fat deposition: A review.

  2023cites this paper
• PPARG agonist pioglitazone influences diurnal kidney medulla mRNA expression of core clock, inflammation‐, and metabolism‐related genes disrupted by reverse feeding in mice

  2022influential citation
• Three-Dimensional Bio-Printed Autologous Omentum Patch Ameliorates Unilateral Ureteral Obstruction-Induced Renal Fibrosis

  2022cites this paper
• Retinoid X Receptor: Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement

  2022cites this paper
• Umbelliferone attenuates glycerol‐induced myoglobinuric acute kidney injury through peroxisome proliferator‐activated receptor‐γ agonism in rats

  2021cites this paper
• PPARγ and TGFβ—Major Regulators of Metabolism, Inflammation, and Fibrosis in the Lungs and Kidneys

  2021cites this paper
• Nuclear Receptors and Transcription Factors in Obesity-Related Kidney Disease.

  2021cites this paper
• Nuclear receptors in podocyte biology and glomerular disease

  2020cites this paper
• Renal cyst growth is attenuated by a combination treatment of tolvaptan and pioglitazone, while pioglitazone treatment alone is not effective

  2020cites this paper
• PPARγ and Its Agonists in Chronic Kidney Disease

  2020cites this paper
• Inhibition of oxygen-sensing prolyl hydroxylases increases lipid accumulation in human primary tubular epithelial cells without inducing ER stress

  2020influential citation
• Expression of Peroxisome Proliferator-activated Receptor-γ in the Kidneys of Cats with Chronic Kidney Disease.

  2020cites this paper
• A Network Pharmacology Approach to Understanding the Mechanisms of Action of Traditional Medicine: Rheum L. for Diabetic Kidney Disease

  2020cites this paper
• Role of TCF7L2 and PPARG2 Gene Polymorphisms in Renal and Cardiovascular Complications among Patients with Type 2 Diabetes: A Cohort Study

  2019cites this paper
• Kidney Pathophysiology, Toxicology, and Drug-Induced Injury in Drug Development

  2019cites this paper
• Obestatin ameliorates water retention in chronic heart failure by downregulating renal aquaporin 2 through GPR39, V2R and PPARG signaling.

  2019cites this paper
• PPARG genotypes are not a major modifiers of chronic kidney disease progression among the diabetic nephropathy patients

  2018cites this paper
• Adipose-specific lipin1 overexpression in mice protects against alcohol-induced liver injury

  2018cites this paper
• Maintenance of Kidney Metabolic Homeostasis by PPAR Gamma

  2018cites this paper
• Association between PPARG Pro 12 Ala polymorphism and diabetic nephropathy risk ; an updated meta-analysis of 27 studies

  2018cites this paper
• Peroxisome proliferator‐activated receptor γ modulates renal crystal retention associated with high oxalate concentration by regulating tubular epithelial cellular transdifferentiation

  2018cites this paper
• Vitamin D, Oxidative Stress, and the Antiretroviral Tenofovir

  2018cites this paper
• Renoprotective Effect of Danhong Injection on Streptozotocin-Induced Diabetic Rats through a Peroxisome Proliferator-Activated Receptor γ Mediated Pathway

  2018cites this paper
• The effects of dual PPARα/γ agonism compared with ACE inhibition in the BTBRob/ob mouse model of diabetes and diabetic nephropathy

  2017cites this paper
• Recent Advances in Management of Diabetic Nephropathy

  2017cites this paper
• Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair

  2017cites this paper
• health and disease Prostacyclin signaling in the kidney: implications for

  2016cites this paper
• Does Thiazolidinedione therapy exacerbate fluid retention in congestive heart failure?

  2016cites this paper
• Anti-inflammatory effect of combination therapy with rosiglitazone and all- trans retinoic acid on high glucose-induced MCP-1 response in rat mesangial cells

  2016cites this paper
• All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway

  2016cites this paper
• Rosiglitazone Promotes AQP2 Plasma Membrane Expression In Renal Cells Via a Ca2+-Dependent/cAMP-Independent Mechanism

  2015cites this paper
• Spontaneously Occurring Formation of Intranuclear and Cytoplasmic Inclusions in Renal Proximal Epithelium Due to Accumulation of d-Amino Acid Oxidase in Wistar Hannover Rats

  2015cites this paper
• Peroxisome proliferator-activated receptor agonists in a battle against the aging kidney

  2014cites this paper
• Proteomic Analysis of Salt-Induced Changes in Protein Expression in PPAR α Null Mice

  2014cites this paper
• PPARγ-Induced Stimulation of Amiloride-Sensitive Sodium Current in Renal Collecting Duct Principal Cells is Serum and Insulin Dependent

  2014cites this paper
• Coordinate regulation between the nuclear receptor peroxisome proliferator-activated receptor-γ and cyclooxygenase-2 in renal epithelial cells.

  2014cites this paper
• The effects of kefir, koumiss, yogurt and commercial probiotic formulations on PPARα and PPAR-β/δ expressions in mouse kidney

  2014cites this paper
• The Rate of Decline of Glomerular Filtration Rate May Not Be Associated with Polymorphism of the PPARγ2 Gene in Patients with Type 1 Diabetes and Nephropathy

  2014cites this paper
• Renal Pathophysiologic Role of Cortical Tubular Inclusion Bodies

  2013cites this paper
• Relationship between anthropometric and haematological parameters among third trimester pregnant women in Sokoto State, Northwest Nigeria.

  2013cites this paper
• Interactions of PPAR α and GLUT4 in DOCA/salt-induced renal injury in mice.

  2013cites this paper
• Inflammation and the pathogenesis of diabetic nephropathy.

  2013cites this paper
• Pathogenesis and Novel Treatment from the Mouse Model of Type 2 Diabetic Nephropathy

  2013cites this paper
• PPAR&ggr; as a therapeutic target in diabetic nephropathy and other renal diseases

  2012cites this paper
• Thiazolidinedione‐dependent activation of sphingosine kinase 1 causes an anti‐fibrotic effect in renal mesangial cells

  2012influential citation
• The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes

  2012cites this paper
• Pharmacological and Toxicological Advances in PPAR-Related Medicines

  2012cites this paper
• LOSS OF RETINOID RECEPTORS RAR-A AND RXR-A DURING MONOCROTALIN/LIPOPOLYSACCHARIDE-INDUCED RENAL TOXICITY IS TISSUE FACTOR DEPENDENT

  2012cites this paper
• The role of nuclear receptors in the kidney in obesity and metabolic syndrome

  2012cites this paper
• Idealized PPARγ-Based Therapies: Lessons from Bench and Bedside

  2012cites this paper
• Expression Profile of Nuclear Receptors along Male Mouse Nephron Segments Reveals a Link between ERRβ and Thick Ascending Limb Function

  2012cites this paper
• Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney.

  2012cites this paper
• Inflammation in the pathogenesis of microvascular complications in diabetes

  2012cites this paper
• Role of TNF-α in Renal Damage in Mice Showing Hepatic Steatosis Induced by High Fat Diet

  2012cites this paper
• Transcriptomic Analysis in Diabetic Nephropathy of Streptozotocin-Induced Diabetic Rats

  2011cites this paper
• Reduction of proteinuria by pioglitazone in patients with non-diabetic renal disease

  2011cites this paper
• Inhibitory Effects of Rosiglitazone on Lipopolysaccharide-Induced Inflammation in a Murine Model and HK-2 Cells

  2011cites this paper
• Therapeutic Effect of Retinoic Acid on Unilateral Ureteral Obstruction Model

  2011cites this paper
• Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats.

  2011cites this paper
• THE ROLE OF PPARγ IN KIDNEY COLLECTING-DUCT by

  2011cites this paper
• Megalin/LRP2 Expression Is Induced by Peroxisome Proliferator-Activated Receptor -Alpha and -Gamma: Implications for PPARs' Roles in Renal Function

  2011cites this paper
• Effects of pioglitazone on renal calcium excretion.

  2011cites this paper
• Advanced glycation end products‐induced apoptosis attenuated by PPARδ activation and epigallocatechin gallate through NF‐κB pathway in human embryonic kidney cells and human mesangial cells

  2010cites this paper
• Increased Renin Production in Mice With Deletion of Peroxisome Proliferator-Activated Receptor-&ggr; in Juxtaglomerular Cells

  2010cites this paper
• Renal PPARγ mRNA expression increases with impairment of renal function in patients with chronic kidney disease

  2010cites this paper
• Beraprost Sodium, an Orally Active Prostaglandin I2 Analog, Improves Renal Anemia in Hemodialysis Patients With Peripheral Arterial Disease

  2010cites this paper
• Rational targeting in acute promyelocytic leukemia.

  2010cites this paper
• Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated Receptors

  2010cites this paper
• Peroxisome Proliferator-Activated Receptors Alpha, Beta, and Gamma mRNA and Protein Expression in Human Fetal Tissues

  2010cites this paper
• Role of PPARgamma in renoprotection in Type 2 diabetes: molecular mechanisms and therapeutic potential.

  2009cites this paper
• Peroxisome Proliferator-Activated Receptor γ Antagonists Decrease Na+ Transport via the Epithelial Na+ Channel

  2009cites this paper
• Peroxisome proliferator-activated receptors and renal diseases.

  2009cites this paper
• How safe is the use of thiazolidinediones in clinical practice?

  2009cites this paper
• Role of G Protein-Coupled Receptor Kinase-2 in Peroxisome Proliferator-Activated Receptor Gamma-Mediated Modulation of Blood Pressure and Renal Vascular Reactivity in SHR

  2009cites this paper
• Review of the expression of peroxisome proliferator-activated receptors alpha (PPAR alpha), beta (PPAR beta), and gamma (PPAR gamma) in rodent and human development.

  2009cites this paper
• Effect of all-trans retinoic acid on renal expressions of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rats with glomerulosclerosis

  2009cites this paper
• PPARγ in Kidney Physiology and Pathophysiology

  2009cites this paper
• Mechanisms of regulation of proximal tubule sodium transporters in obesity-induced hypertension

  2009cites this paper
• ReviewArticle PPARγ in Kidney Physiology and Pathophysiology

  2008cites this paper
• Title The protective role of bone morphogenetic protein-7 against mesangial cell injury in IgA nephropathy

  2008cites this paper
• A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.

  2008cites this paper
• Chronic Rosiglitazone Therapy Normalizes Expression of ACE1, SCD1 and other Genes in the Kidney of Obese Zucker Rats as Determined by Microarray Analysis

  2008cites this paper
• Relationship between peroxisome proliferator-activated receptor-γ and renal ischemia-reperfusion injury.

  2008cites this paper
• Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARγ agonist pioglitazone

  2008cites this paper
• Propiverine-induced accumulation of nuclear and cytosolic protein in F344 rat kidneys: isolation and identification of the accumulating protein.

  2008cites this paper
• Time course of AQP-2 and ENaC regulation in the kidney in response to PPAR agonists associated with marked edema in rats.

  2008cites this paper
• Antiproteinuric and anti‐inflammatory effects of thiazolidinedione (Review Article)

  2008cites this paper
• Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention

  2008cites this paper
• Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury.

  2008cites this paper
• Renal Cytochrome P450 as a Determinant of Impaired Natriuresis by PPAR‐γ Ligands in Ovariectomized Obese Rats

  2008influential citation
• Functional genomics in the stroke-prone spontaneously hypertensive rat : genome wide and candidate gene analysis

  2008cites this paper
• Peroxisomal Proliferator-Activated Receptor- (cid:1) Protects Renal Tubular Cells from Doxorubicin-Induced Apoptosis

  2007cites this paper
• Effets néphroprotecteurs des glitazones

  2007cites this paper
• The Glitazones, Lessons so Far

  2007cites this paper
• Pharmacotherapy of Diabetes

  2007cites this paper
• Peroxisomal proliferator-activated receptor-alpha protects renal tubular cells from doxorubicin-induced apoptosis.

  2007cites this paper
• Peroxisomal proliferator-activated receptor-alpha (PPAR-α) protects renal tubular cells from adriamycin-induced apoptosis

  2007cites this paper
• Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Agonists Attenuate the Profibrotic Response Induced by TGF-β1 in Renal Interstitial Fibroblasts

  2007cites this paper